Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human 5HT1A Receptor ELISA Kit (AC3283)
Cat.#: ASET-1872
Specifications
Description Human 5HT1A Receptor ELISA Kit allows for the in vitro quantitative determination of human 5HT1A Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1688 Human VEGFC ELISA Kit (AC3099) Quantitative inquiry ASET-2129 Human Hyaluronan Synthase 2 ELISA Kit (AC3540) Quantitative inquiry ASET-2160 Mouse Ndnf ELISA Kit (AC3571) Quantitative inquiry ASET-2034 Rat Contactin 1 ELISA Kit (AC3445) Quantitative inquiry ASET-2265 Mouse Hes1 ELISA Kit (AC3676) Quantitative inquiry ASET-1922 Porcine Heme Oxygenase 1 ELISA Kit (AC3333) Quantitative inquiry ASET-2090 Human PCDHB16 ELISA Kit (AC3501) Quantitative inquiry ASET-1121 Human TBX1 ELISA Kit (AC2532) Quantitative inquiry ASET-1835 Human Hemojuvelin ELISA Kit (AC3246) Quantitative inquiry ASET-2142 Human BACE1 ELISA Kit (AC3553) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket